169 related articles for article (PubMed ID: 36315933)
1. Imaging of K
Thale I; Maskri S; Grey L; Todesca LM; Budde T; Maisuls I; Strassert CA; Koch O; Schwab A; Wünsch B
ChemMedChem; 2023 Jan; 18(2):e202200551. PubMed ID: 36315933
[TBL] [Abstract][Full Text] [Related]
2. Co-staining of K
Brömmel K; Maskri S; Bulk E; Pethő Z; Rieke M; Budde T; Koch O; Schwab A; Wünsch B
ChemMedChem; 2020 Dec; 15(24):2462-2469. PubMed ID: 33043595
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of Small-Molecule Fluorescent Probes for the In Vitro Imaging of Calcium-Activated Potassium Channel K
Brömmel K; Maskri S; Maisuls I; Konken CP; Rieke M; Pethő Z; Strassert CA; Koch O; Schwab A; Wünsch B
Angew Chem Int Ed Engl; 2020 May; 59(21):8277-8284. PubMed ID: 32097518
[TBL] [Abstract][Full Text] [Related]
4. Imaging of the calcium activated potassium channel 3.1 (K
Konken CP; Heßling K; Thale I; Schelhaas S; Dabel J; Maskri S; Bulk E; Budde T; Koch O; Schwab A; Schäfers M; Wünsch B
Arch Pharm (Weinheim); 2022 Dec; 355(12):e2200388. PubMed ID: 36161669
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic dysregulation of KCa 3.1 channels induces poor prognosis in lung cancer.
Bulk E; Ay AS; Hammadi M; Ouadid-Ahidouch H; Schelhaas S; Hascher A; Rohde C; Thoennissen NH; Wiewrodt R; Schmidt E; Marra A; Hillejan L; Jacobs AH; Klein HU; Dugas M; Berdel WE; Müller-Tidow C; Schwab A
Int J Cancer; 2015 Sep; 137(6):1306-17. PubMed ID: 25704182
[TBL] [Abstract][Full Text] [Related]
6. The Use of PET Imaging for Prognostic Integrin α
Huang CW; Hsieh WC; Hsu ST; Lin YW; Chung YH; Chang WC; Chiu H; Lin YH; Wu CP; Yen TC; Huang FT
Theranostics; 2017; 7(16):4013-4028. PubMed ID: 29109795
[TBL] [Abstract][Full Text] [Related]
7. Treatment with senicapoc, a K
Petersen AG; Lind PC; Mogensen S; Jensen AB; Granfeldt A; Simonsen U
Br J Pharmacol; 2022 May; 179(10):2175-2192. PubMed ID: 34623632
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of PET tracers designed for imaging of calcium activated potassium channel 3.1 (K
Brömmel K; Konken CP; Börgel F; Obeng-Darko H; Schelhaas S; Bulk E; Budde T; Schwab A; Schäfers M; Wünsch B
RSC Adv; 2021 Sep; 11(48):30295-30304. PubMed ID: 35480282
[TBL] [Abstract][Full Text] [Related]
9. K
Glaser F; Hundehege P; Bulk E; Todesca LM; Schimmelpfennig S; Nass E; Budde T; Meuth SG; Schwab A
Sci Rep; 2021 Sep; 11(1):18330. PubMed ID: 34526525
[TBL] [Abstract][Full Text] [Related]
10. Development of PEGylated peptide probes conjugated with (18)F-labeled BODIPY for PET/optical imaging of MT1-MMP activity.
Kondo N; Temma T; Deguchi J; Sano K; Ono M; Saji H
J Control Release; 2015 Dec; 220(Pt A):476-483. PubMed ID: 26578437
[TBL] [Abstract][Full Text] [Related]
11. K
Bulk E; Kramko N; Liashkovich I; Glaser F; Schillers H; Schnittler HJ; Oberleithner H; Schwab A
Oncotarget; 2017 Dec; 8(68):112268-112282. PubMed ID: 29348824
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of the small conductance Ca(2+) -activated K(+) channels is potently cytotoxic in breast cancer cell lines.
Abdulkareem ZA; Gee JM; Cox CD; Wann KT
Br J Pharmacol; 2016 Jan; 173(1):177-90. PubMed ID: 26454020
[TBL] [Abstract][Full Text] [Related]
13. ImmunoPET Imaging of CD146 in Murine Models of Intrapulmonary Metastasis of Non-Small Cell Lung Cancer.
England CG; Jiang D; Hernandez R; Sun H; Valdovinos HF; Ehlerding EB; Engle JW; Yang Y; Huang P; Cai W
Mol Pharm; 2017 Oct; 14(10):3239-3247. PubMed ID: 28825843
[TBL] [Abstract][Full Text] [Related]
14. A Novel PET Probe for Brown Adipose Tissue Imaging in Rodents.
Wang H; Wang M; Chansaenpak K; Liu Y; Yuan H; Xie J; Yin H; Branca RT; Li Z; Wu Z
Mol Imaging Biol; 2020 Jun; 22(3):675-684. PubMed ID: 31520279
[TBL] [Abstract][Full Text] [Related]
15. ImmunoPET Imaging of CTLA-4 Expression in Mouse Models of Non-small Cell Lung Cancer.
Ehlerding EB; England CG; Majewski RL; Valdovinos HF; Jiang D; Liu G; McNeel DG; Nickles RJ; Cai W
Mol Pharm; 2017 May; 14(5):1782-1789. PubMed ID: 28388076
[TBL] [Abstract][Full Text] [Related]
16. CD38 as a PET Imaging Target in Lung Cancer.
Ehlerding EB; England CG; Jiang D; Graves SA; Kang L; Lacognata S; Barnhart TE; Cai W
Mol Pharm; 2017 Jul; 14(7):2400-2406. PubMed ID: 28573863
[TBL] [Abstract][Full Text] [Related]
17. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
18. Expression of a Diverse Array of Ca2+-Activated K+ Channels (SK1/3, IK1, BK) that Functionally Couple to the Mechanosensitive TRPV4 Channel in the Collecting Duct System of Kidney.
Li Y; Hu H; Butterworth MB; Tian JB; Zhu MX; O'Neil RG
PLoS One; 2016; 11(5):e0155006. PubMed ID: 27159616
[TBL] [Abstract][Full Text] [Related]
19. Calcium-activated potassium channels mediated blood-brain tumor barrier opening in a rat metastatic brain tumor model.
Hu J; Yuan X; Ko MK; Yin D; Sacapano MR; Wang X; Konda BM; Espinoza A; Prosolovich K; Ong JM; Irvin D; Black KL
Mol Cancer; 2007 Mar; 6():22. PubMed ID: 17359538
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography in relation to Noguchi's classification for diagnosis of peripheral non-small-cell lung cancer 2 cm or less in size.
Tsunezuka Y; Shimizu Y; Tanaka N; Takayanagi T; Kawano M
World J Surg; 2007 Feb; 31(2):314-7. PubMed ID: 17219276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
